# Use of Serological Tests to Reduce the Risk of Transmission of Trypanosoma cruzi Infection in Blood and Blood Components:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/use-of-serological-tests-to-reduce-the-risk-of-transmission-of-trypanosoma-cruzi-infection-in-blood-and-blood-components-guidance-for-industry/56941716-f51b-48de-a18b-b6d0a37a66e6

> FDA guidance document: Use of Serological Tests to Reduce the Risk of Transmission of Trypanosoma cruzi Infection in Blood and Blood Components:  Guidance for Industry. Issue date: December 05, 2017. Get complete insights and analysis.

---

## Details

- Title: Use of Serological Tests to Reduce the Risk of Transmission of Trypanosoma cruzi Infection in Blood and Blood Components:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2017-12-05
- Comment Close Date: 2017-12-06
- Last Changed: 2020-10-22
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2009-D-0137">FDA-2009-D-0137</a>

## Related Documents

- [Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/recommendations-for-evaluating-donor-eligibility-using-individual-risk-based-questions-to-reduce-the-risk-of-human-immunodeficiency-virus-transmission-by-blood-and-blood-products-guidance-for-industry/2aa5412b-2ce3-4c75-b71e-e133b6e6afe5)
- [Use of Serological Tests to Reduce the Risk of Transfusion-Transmitted Human T-Lymphotropic Virus Types I and II (HTLV-I/II):  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/use-of-serological-tests-to-reduce-the-risk-of-transfusion-transmitted-human-t-lymphotropic-virus-types-i-and-ii-htlv-iii-guidance-for-industry/e8ad35aa-47eb-47df-bcd6-5f95ecae4ee9)
- [Labeling of Red Blood Cell Units with Historical Antigen Typing Results:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/labeling-of-red-blood-cell-units-with-historical-antigen-typing-results-guidance-for-industry/39eceff8-0db3-40ad-a2f9-d7dc1cf7df08)